Egypt: Omicron Cases Requiring Intensive Care 'Remain At Safe Rates'
[Egypt Online] Acting Health Minister Khaled Abdel Ghaffar said Sunday the coronavirus infections have seen an increase all over the globe and in Egypt due to the fast-spreading Omicron variant. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - January 17, 2022 Category: African Health Source Type: news

COVID-19 Severity Before and During Delta Predominance COVID-19 Severity Before and During Delta Predominance
Does the SARS-CoV-2 B.1.617.2 (Delta) variant cause more severe disease in adults than other variants?Morbidity & Mortality Weekly Report (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 17, 2022 Category: Intensive Care Tags: Public Health & Prevention Journal Article Source Type: news

Don ’t demonise those who refuse the Covid vaccine | Letters
One reader ’s experience of the effects on family members of the conspiracy theories surrounding vaccinationsI read David Green ’sletter on anti-vaxxers (12 January) and empathised with theletter written in response (13 January). The week before Christmas my dad died of Covid. The intensive care consultant couldn ’t have been clearer that, in her opinion, if he had been vaccinated he would not have developed Covid pneumonia to the severity that he did.He died very frightened and asking his family to come and be with him, and we couldn ’t. The experience traumatised my sister so badly that she was hospitalised with ...
Source: Guardian Unlimited Science - January 16, 2022 Category: Science Authors: Letters Tags: Coronavirus Vaccines and immunisation Health Infectious diseases Medical research Science Society Source Type: news

Almost All Teens in ICU With COVID Were Unvaccinated, Study Shows Almost All Teens in ICU With COVID Were Unvaccinated, Study Shows
Nearly all teenagers admitted to intensive care units because of COVID-19 were unvaccinated, according to a new study published in the New England Journal of Medicine.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - January 14, 2022 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

The U.S. Is Facing Shortages in COVID-19 Drugs as Omicron Rages
Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the Omicron wave of infections. The problem is that production is not yet at full strength and that the pill considered to be far superior, Pfizer’s, takes six to eight months to manufacture. While the supply is expected to improve dramatically in the coming months, doctors are clamoring for the pills now, not just because Omicron is causing an explosion of cases but because two antibody drugs that were once the go-to treatments don’t wor...
Source: TIME: Health - January 13, 2022 Category: Consumer Health News Authors: MATTHEW PERRONE/AP Tags: Uncategorized COVID-19 Drugs healthscienceclimate wire Source Type: news

Shorter Course of Anticoagulant Therapy Adequate for Provoked VTE in Children Shorter Course of Anticoagulant Therapy Adequate for Provoked VTE in Children
For children with acute provoked venous thromboembolism, 6 weeks of anticoagulant therapy is as effective as a three-month course of anticoagulant therapy, results of a new clinical trial suggest.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 13, 2022 Category: Intensive Care Tags: Critical Care News Source Type: news

IV Immunoglobulin Therapy in COVID-19 Related ARDS IV Immunoglobulin Therapy in COVID-19 Related ARDS
A new study looks at the outcomes of IVIG-treated COVID-19 patients with acute respiratory distress syndrome. Is this an effective therapy?BMC Pulmonary Medicine (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 12, 2022 Category: Intensive Care Tags: Pulmonary Medicine Journal Article Source Type: news

Time From Intubation to Cannulation in VV-ECMO for COVID-19 Time From Intubation to Cannulation in VV-ECMO for COVID-19
When is the optimal time to initiate VV-ECMO for critically ill COVID-19 patients?Critical Care (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 12, 2022 Category: Intensive Care Tags: Pulmonary Medicine Journal Article Source Type: news

Roche launches the cobas ® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care
Rochelaunches thecobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient careHandheld blood glucose management device designed around the specific needs of healthcare professionals working in a range of care settingsFirst diagnostic solution at the point of care to serve as a digital platform connecting developers of digital health software and applications to healthcare professionalsNew system simplifies workflows and equips healthcare professionals with valuable clinical insights to deliver better patient careBasel, 12 January 2022 ...
Source: Roche Media News - January 12, 2022 Category: Pharmaceuticals Source Type: news

A Quality Improvement Initiative to Evaluate the Effectiveness of the ABCDEF Bundle on Sepsis Outcomes
Sepsis affects 1.7 million Americans annually and often requires an intensive care unit (ICU) stay. Survivors of ICU can experience long-term negative effects. This quality improvement initiative was designed to increase compliance with ABCDEF bundle elements and improve clinical outcomes. A significant improvement was seen in the completion of spontaneous awakening and breathing trials (P = .002), delirium assessment (P = .041), and early mobility (P = .000), which was associated with a reduction in mortality and 30-day readmission rates. Findings were consistent with other research that demonstrated an improvement in car...
Source: Current Awareness Service for Health (CASH) - January 11, 2022 Category: Consumer Health News Source Type: news

Prevalence and predictors of hospital-acquired functional decline in patients with sepsis admitted to the intensive care unit.
In conclusion, nearly half of the patients with sepsis who received rehabilitation developed HAFD. Lower functional status prior to hospitalization and the longer time to initial ambulation was associated with HAFD, indicating the pot ential importance of early ambulation among septic patients in the ICU. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 11, 2022 Category: Consumer Health News Source Type: news

Hyperbaric Oxygen Resolves COVID-19 Breathing Problems Much Faster Hyperbaric Oxygen Resolves COVID-19 Breathing Problems Much Faster
Hyperbaric oxygen appears to resolves severe COVID-19 breathing problems in a median of 3 days compared with 9 days with standard therapy, researchers in Argentina report.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 10, 2022 Category: Intensive Care Tags: Emergency Medicine News Source Type: news

Covid: Fact-checking the doctor who challenged the health secretary
An intensive-care doctor challenged the health secretary over mandatory vaccination - are his claims right? (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 10, 2022 Category: Consumer Health News Source Type: news

How Families Can Navigate the I.C.U.
A new book offers guidance on how family members can support a critically ill loved one who ends up in the hospital ’s intensive care unit. (Source: NYT Health)
Source: NYT Health - January 10, 2022 Category: Consumer Health News Authors: Jane E. Brody Tags: Families and Family Life Post-Traumatic Stress Disorder Living Wills and Health Care Proxies Death and Dying Hospitals Source Type: news

Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States
NEW BRUNSWICK, N.J., January 6, 2022 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced new results from the largest study to date on the durability of COVID-19 vaccines in the United States (U.S.), showing that a single shot of the Johnson & Johnson COVID-19 vaccine resulted in long-lasting protection for up to six months against COVID-19 breakthrough infections, hospitalizations, and intensive care unit (ICU) admissions. The study was sponsored by the Janssen Pharmaceutical Companies of Johnson & Johnson and conducted in partnership with the Department of Science-Aetion, Inc, and the Division of ...
Source: Johnson and Johnson - January 6, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news